Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Pan-Cancer Analysis of the Solute Carrier Family 39 Genes in Relation to Oncogenic, Immune Infiltrating, and Therapeutic Targets

2 Dec 2021

Abstract excerpt

Background: Emerging pieces of evidence demonstrated that the solute carrier family 39 (SLC39A) members are critical for the oncogenic and immune infiltrating targets in multiple types of tumors. However, the precise relationship between the SLC39A family genes and clinical prognosis as well as the pan-cancer tumor cell infiltration has not been fully elucidated. Methods: In this study, the pan-cancer expression...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Drug Transport and Resistance Mechanisms
Share to Epigenetics and DNA Methylation
Share to Ferroptosis and cancer prognosis

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 34925450
DOI: 10.3389/fgene.2021.757582

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Pan-Cancer Analysis of the Solute Carrier Family 39 Genes in Relation to Oncogenic, Immune Infiltrating, and Therapeutic TargetsPMID 34925450Read ↗

Comprehensive analysis of 33 human cancers reveals clinical implications and immunotherapeutic value of the solute carrier family 35 member A2.Semantic proximity Read ↗

Unveiling the prognostic and therapeutic landscape of the zinc transporter protein SLC39A family in colorectal cancer through multi-omics and machine learning approaches.Semantic proximity Read ↗

Analysis of the prognostic significance of solute carrier (SLC) family 39 genes in breast cancer.Semantic proximity Read ↗

Comprehensive pan-cancer analysis identified SLC16A3 as a potential prognostic and diagnostic biomarkerSemantic proximity Read ↗

SLC39A1 Contribute to Malignant Progression and Have Clinical Prognostic Impact in GliomasSemantic proximity Read ↗

Comprehensive analyses of solute carrier family members identify SLC12A2 as a novel therapy target for colorectal cancer.Semantic proximity Read ↗

SLC39A1 contribute to malignant progression and have clinical prognostic impact in gliomasSemantic proximity Read ↗

Metal Ion Transporter SLC39A14-Mediated Ferroptosis and Glycosylation Modulate the Tumor Immune Microenvironment: A Pan-Cancer Multi-Omics Exploration of Therapeutic PotentialSemantic proximity Read ↗

Identification of a Solute Carrier Family-Based Signature for Predicting Overall Survival in OsteosarcomaSemantic proximity Read ↗

SLC12A9 is an immunological and prognostic biomarker for glioma.Semantic proximity Read ↗

SLC1A5 is a novel biomarker associated with ferroptosis and the tumor microenvironment: a pancancer analysisSemantic proximity Read ↗

A Pan-Cancer Analysis of SLC12A5 Reveals Its Correlations with Tumor Immunity.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.